Skip to content
Checked.be
Complete company report
Generated 17-08-2026
Active BE 0884.084.724Public limited company

OMEGA PHARMA INNOVATION & DEVELOPMENT

Gaston Crommenlaan 6 ·9050 Gent, Belgium· 19 yrs active
Sector: Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied (72109)
Conclusion Checked

The computed 12-month bankruptcy probability of OMEGA PHARMA INNOVATION & DEVELOPMENT is 0.3% (very low). The company has been active since 2006 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.
Key figures
Active 19 yrs
Board 4
Locations 1
Publications 21
Bankruptcy probability (12 mo) Checked model v1 · free
0.3% Very low
0%0,5%1,5%4%10%≥25%
Lower-failure-rate sector −Long track record −Lower-risk legal form −

Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?

Risk Assessment rule-based
0 / 100
Low risk
Trust signals 2 signals
Established
Founded in 2006, 19 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags0 events
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview10 NBB filings
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
Fiscal year Type Filed Reference
31-12-2024 volledig 18-06-2025 2025-00191173
31-12-2023 volledig 22-05-2024 2024-00101929
31-12-2022 volledig 25-05-2023 2023-00100902
31-12-2021 volledig 17-06-2022 2022-20087481
31-12-2020 volledig 14-06-2021 2021-19900486
31-12-2019 volledig 11-06-2020 2020-17000087
31-12-2018 volledig 27-05-2019 2019-14600318
31-12-2017 volledig 22-06-2018 2018-21900226
31-12-2016 volledig 14-11-2017 2017-69700208
31-12-2015 volledig 15-07-2016 2016-32300298
Directors & mandates 10 directors
Current directors & mandates
  • Jonas Dhaenens
    Director
    State Gazette act 26072803 (08-06-2026)
    Current
    22-05-2026 → present
  • Sonia Hollies
    Director
    State Gazette act 24148118 (15-10-2024)
    Current
    29-08-2024 → present
    2 events
    • 29-08-2024 Appointed· Director
    • 29-08-2024 Appointed· Managing director
  • Magali Verbraeken
    Director
    State Gazette act 23029640 (01-03-2023)
    Current
    23-01-2023 → present
  • Gianluca Parola
    Director
    State Gazette act 21107706 (09-09-2021)
    Current
    29-07-2021 → present
Historic, not recently confirmed (4)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
  • Pachtersbos BVLegal entity
    Director· perm. rep.: Lieven Costers
    State Gazette act 20084990 (24-07-2020)
    Not recently confirmed
    last confirmed in an act from 2020
  • Brandracer BVBALegal entity
    Director· perm. rep.: Geert Cools
    State Gazette act 17141462 (06-10-2017)
    Not recently confirmed
    last confirmed in an act from 2017
    2 events
    • 06-10-2017 Appointed· Director
    • 22-02-2016 Appointed· Director
  • Pachtersbos BVBALegal entity
    Director· perm. rep.: Lieven Costers
    State Gazette act 17141462 (06-10-2017)
    Not recently confirmed
    last confirmed in an act from 2017
  • Patrick O'Sullivan
    Director
    State Gazette act 17141462 (06-10-2017)
    Not recently confirmed
    last confirmed in an act from 2017
Former directors (2)
  • Anja van Winsberghe
    Director
    State Gazette act 21065116 (02-06-2021)
    Former
    17-05-2021 → 22-05-2026
    2 events
    • 22-05-2026 Resigned· Director
    • 17-05-2021 Appointed· Director
  • Mira De Maeyer
    Director
    State Gazette act 24041618 (07-03-2024)
    Former
    01-01-2024 → 29-08-2024
    2 events
    • 29-08-2024 Resigned· Director
    • 01-01-2024 Appointed· Director
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor 4 auditor
Statutory auditor IRE/IBR number Tenure
BDO Bedrijfsrevisoren bvCurrent
Statutory auditor · represented by Evy Borry
 - 20-05-2025 → present
Show 3 earlier auditors
Ernst & Young Bedrijfsrevisoren BCVBA
Statutory auditor · represented by Paul Eelen
succeeded by EY Bedrijfsrevisoren BV in 2021
 - 09-07-2018 → 17-05-2021
EY Bedrijfsrevisoren BV
Statutory auditor · represented by Paul Eelen
succeeded by BDO Bedrijfsrevisoren bv in 2025
 - 17-05-2021 → 20-05-2025
PricewaterhouseCoopers, Bedrijfsrevisoren
Statutory auditor · represented by Peter Opsomer
succeeded by Ernst & Young Bedrijfsrevisoren BCVBA in 2018
 - 23-03-2011 → 09-07-2018
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
NACE primary Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied(72109)
Legal form Public limited company(014)
Incorporation09-10-2006
StatusActive
Postal code9050
Connections & network 7 connected companies
Network connections
Oce-Bio
Shared address
→
→
OMEGA PHARMA TRADING
Shared address
→
Perrigo Belgium
Shared address
→
Show 2 more network connections
Perrigo Capital
Shared address
→
Perrigo Europe Invest
Shared address
→
1 further connected company in this network. Available in Kantoor S. See plans →
Connections derived from shared directors, addresses, shareholders and group structure in the Belgian State Gazette.
Establishment units 1 location
Omega Pharma Innovation & Development
Venecoweg 26, 9810 Nazareth-De PinteProductie van legeringen van edele metalen
since 20062.159.666.792
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint Source: CBE × cadastre

Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.

Flanders 2 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44032A0472/00R003 Flanders 1.9 ha 1 · 8,006 m² -
44048A0132/00Y002 Flanders 1.8 ha 1 · 4,733 m² 13.5 m · 3 fl.
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates 31 events

A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.

2026
08-06-2026
State Gazette act Open capture
General meeting · Officer resignation · Officer discharge · Officer appointment
2025
22-12-2025
State Gazette act Director changes
v3.2
18-06-2025
NBB filing Annual accounts filed
fiscal year 2024 · volledig
2024
15-10-2024
State Gazette act Director changes
v3.2
18-06-2024
State Gazette act Director changes
v3.2
22-05-2024
NBB filing Annual accounts filed
fiscal year 2023 · volledig
15-03-2024
State Gazette act Registered-office change
v3.2
07-03-2024
State Gazette act Director changes
v3.2
2023
25-05-2023
NBB filing Annual accounts filed
fiscal year 2022 · volledig
01-03-2023
State Gazette act Director changes
v3.2
05-01-2023
State Gazette act Director changes
v3.2
2022
17-06-2022
NBB filing Annual accounts filed
fiscal year 2021 · volledig
2021
09-09-2021
State Gazette act Director changes
v3.2
02-09-2021
State Gazette act Statutes amendment
v3.2
17-06-2021
State Gazette act Miscellaneous
proposal · Anja Van Winsberghe
14-06-2021
NBB filing Annual accounts filed
fiscal year 2020 · volledig
02-06-2021
State Gazette act Director changes
v3.2
2020
24-07-2020
State Gazette act Director changes
v3.2
11-06-2020
NBB filing Annual accounts filed
fiscal year 2019 · volledig
2019
28-05-2019
State Gazette act Minor change
v3.2
27-05-2019
NBB filing Annual accounts filed
fiscal year 2018 · volledig
2018
09-07-2018
State Gazette act Director changes
v3.2
22-06-2018
NBB filing Annual accounts filed
fiscal year 2017 · volledig
2017
14-11-2017
NBB filing Annual accounts filed
fiscal year 2016 · volledig
06-10-2017
State Gazette act Director changes
v3.2
2016
15-07-2016
NBB filing Annual accounts filed
fiscal year 2015 · volledig
20-04-2016
State Gazette act Director changes
v3.2
2015
27-07-2015
State Gazette act Director changes
v3.2
2011
23-03-2011
State Gazette act Director changes
v3.2
03-01-2011
State Gazette act Minor change
v3.2
2009
10-07-2009
State Gazette act Registered-office change
v3.2
Belgian State Gazette reading coverage 0 of 37 acts read

We know of 37 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Belgisch Staatsblad, acts 21 acts
Address history · 2
15-03-2024
v3.2
10-07-2009
v3.2
All acts · 21 updated 2 months ago
2026
08-06-2026 General meeting · Officer resignation · Officer discharge · Officer appointment Open-capture extraction
  • Filing: 2026-05-29 · Omega Pharma Innovation & Development NV
  • General meeting: 2026-05-20 · Omega Pharma Innovation & Development NV
  • Officer resignation: role: bestuurder, effective_date: 2026-05-22 · Anja van Winsberghe
  • Officer discharge: role: bestuurder · Anja van Winsberghe
  • Officer appointment: role: bestuurder, effective_date: 2026-05-22 · Jonas Dhaenens
  • Mandate term: role: bestuurder, end_condition: datum van de jaarvergadering die zal worden gehouden in het jaar 2032 · Jonas Dhaenens
  • Mandate compensation: role: bestuurder, compensation: onbezoldigd · Jonas Dhaenens
  • Power of attorney: mode: gezamenlijk of afzonderlijk handelend, en met recht van indeplaatsstelling · Omega Pharma Innovation & Development NV
  • Publication: 2026-06-08 · Omega Pharma Innovation & Development NV
  • Act object: Ontslagen - benoemingen
  • Power of attorney · Omega Pharma Innovation & Development NV
  • Power of attorney · Omega Pharma Innovation & Development NV
  • Power of attorney · Omega Pharma Innovation & Development NV
  • Power of attorney · Omega Pharma Innovation & Development NV
Summary: General meeting · Officer resignation · Officer discharge · Officer appointment
Technical details 
{
  "facts": [
    {
      "type": "filing",
      "quote": "NEERLEGGING TER GRIFFIE VAN DE ONDERNEMINGSRECHTBANK CENTRAAL GENT 29 MEI 2026",
      "value": "2026-05-29",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "general_meeting",
      "quote": "Uittreksel uit de schriftelijke besluiten van de enige aandeelhouder van Omega Pharma Innovation \u0026 Development NV d.d. 20 mei 2026",
      "value": "2026-05-20",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "officer_resignation",
      "quote": "De enige aandeelhouder beslist om het mandaat van mevrouw Anja van Winsberghe als bestuurder van de Vennootschap te be\u00EBindigen met ingang vanaf 22 mei 2026.",
      "value": {
        "role": "bestuurder",
        "effective_date": "2026-05-22"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "officer_discharge",
      "quote": "De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "value": {
        "role": "bestuurder"
      },
      "object": "e1",
      "subject": "e2"
    },
    {
      "type": "officer_appointment",
      "quote": "De enige aandeelhouder beslist om de heer Jonas Dhaenens, met domicilie te Brandveld 29, 9500 Geraardsbergen, Belgi\u00EB, te benoemen als bestuurder van de Vennootschap met ingang vanaf 22 mei 2026.",
      "value": {
        "role": "bestuurder",
        "effective_date": "2026-05-22"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "mandate_term",
      "quote": "Het bestuursmandaat zal eindigen op datum van de jaarvergadering die zal worden gehouden in het jaar 2032.",
      "value": {
        "role": "bestuurder",
        "end_condition": "datum van de jaarvergadering die zal worden gehouden in het jaar 2032"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "mandate_compensation",
      "quote": "Het bestuursmandaat zal onbezoldigd worden uitgeoefend.",
      "value": {
        "role": "bestuurder",
        "compensation": "onbezoldigd"
      },
      "object": "e1",
      "subject": "e3"
    },
    {
      "type": "power_of_attorney",
      "quote": "De enige aandeelhouder beslist om een bijzondere volmacht te verlenen aan elke bestuurder van de Vennootschap en aan Bart Bellen, Ine Schockaert, Charlotte Van Weehaeghe, Marthe Wouters of enige andere advocaat of medewerker van het advocatenkantoor contrast (Minervastraat 5, 1930 Zaventem), gezamenlijk of afzonderlijk handelend, en met recht van indeplaatsstelling, om in naam van de Vennootschap (i) de bijzondere verklaring in toepassing van artikel 13 van de wet van 4 mei 2023 betreffende het Centraal register van bestuursverboden op te stellen en te ondertekenen, (ii) deze beslissingen in de Bijlagen bij het Belgisch Staatsblad te publiceren, en (iii) het dossier van de Vennootschap bij de KBO aan te passen.",
      "value": {
        "mode": "gezamenlijk of afzonderlijk handelend, en met recht van indeplaatsstelling",
        "scope": [
          "de bijzondere verklaring in toepassing van artikel 13 van de wet van 4 mei 2023 betreffende het Centraal register van bestuursverboden op te stellen en te ondertekenen",
          "deze beslissingen in de Bijlagen bij het Belgisch Staatsblad te publiceren",
          "het dossier van de Vennootschap bij de KBO aan te passen"
        ],
        "granted_to": [
          "elke bestuurder van de Vennootschap",
          "Bart Bellen",
          "Ine Schockaert",
          "Charlotte Van Weehaeghe",
          "Marthe Wouters",
          "enige andere advocaat of medewerker van het advocatenkantoor contrast"
        ]
      },
      "object": null,
      "subject": "e1"
    },
    {
      "type": "publication",
      "quote": "Bijlagen bij het Belgisch Staatsblad - 08/06/2026 - Annexes du Moniteur belge",
      "value": "2026-06-08",
      "object": null,
      "subject": "e1"
    },
    {
      "type": "act_object",
      "quote": "Onderwerp akte: Ontslagen - benoemingen",
      "value": "Ontslagen - benoemingen",
      "object": null,
      "subject": null
    },
    {
      "type": "power_of_attorney",
      "quote": "Bart Bellen",
      "value": null,
      "object": "e4",
      "subject": "e1",
      "needs_verify": true
    },
    {
      "type": "power_of_attorney",
      "quote": "Ine Schockaert",
      "value": null,
      "object": "e5",
      "subject": "e1",
      "needs_verify": true
    },
    {
      "type": "power_of_attorney",
      "quote": "Charlotte Van Weehaeghe",
      "value": null,
      "object": "e6",
      "subject": "e1",
      "needs_verify": true
    },
    {
      "type": "power_of_attorney",
      "quote": "Marthe Wouters",
      "value": null,
      "object": "e7",
      "subject": "e1",
      "needs_verify": true
    }
  ],
  "act_meta": {
    "model_id": 40,
    "extractor": "open-capture-27b-v3",
    "ocr_chars": 2422,
    "truncated": false,
    "needs_verify": false
  },
  "entities": [
    {
      "id": "e1",
      "kbo": "0884.084.724",
      "kind": "company",
      "name": "Omega Pharma Innovation \u0026 Development NV",
      "attrs": {
        "seat": "Gaston Crommenlaan 6, bus 606, 9050 Gent",
        "legal_form": "Naamloze vennootschap"
      }
    },
    {
      "id": "e2",
      "kbo": null,
      "kind": "person",
      "name": "Anja van Winsberghe",
      "attrs": {}
    },
    {
      "id": "e3",
      "kbo": null,
      "kind": "person",
      "name": "Jonas Dhaenens",
      "attrs": {
        "domicile": "Brandveld 29, 9500 Geraardsbergen, Belgi\u00EB"
      }
    },
    {
      "id": "e4",
      "kbo": null,
      "kind": "person",
      "name": "Bart Bellen",
      "attrs": {}
    },
    {
      "id": "e5",
      "kbo": null,
      "kind": "person",
      "name": "Ine Schockaert",
      "attrs": {}
    },
    {
      "id": "e6",
      "kbo": null,
      "kind": "person",
      "name": "Charlotte Van Weehaeghe",
      "attrs": {}
    },
    {
      "id": "e7",
      "kbo": null,
      "kind": "person",
      "name": "Marthe Wouters",
      "attrs": {}
    },
    {
      "id": "e8",
      "kbo": null,
      "kind": "org",
      "name": "contrast",
      "attrs": {
        "address": "Minervastraat 5, 1930 Zaventem"
      }
    }
  ]
}
2025
22-12-2025 Evy Borry appointed as statutory auditor Director changes
  • Evy Borry, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Evy Borry",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BDO Bedrijfsrevisoren BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2025-05-20",
      "evidence_quote": "De enige aandeelhouder beslist om BDO Bedrijfsrevisoren BV, met zetel te Elsinore Building - Corporate Village, Da Vincilaan 9, bus E.6, 1930 Zaventem, vast vertegenwoordigd door Evy Borry, bedrijfsrevisor, te benoemen als commissaris van de Vennootschap, met ingang vanaf 20 mei 2025"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2024
15-10-2024 2 directors appointed, 1 resigning Director changes
  • Sonia Hollies, Bestuurder
  • Sonia Hollies, Gedelegeerd bestuurder
  • Mira De Maeyer, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_out",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De enige aandeelhouder beslist om het mandaat van mevrouw Mira De Maeyer als bestuurder van de Vennootschap te be\u00EBindiging met ingang vanaf heden. De enige aandeelhouder beslist om kwijting te verlenen voor de uitoefening van haar mandaat tot op heden.",
      "discharge_granted": true
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De enige aandeelhouder beslist om mevrouw Sonia Hollies te benoemen als bestuurder van de Vennootschap met ingang vanaf heden."
    },
    {
      "kind": "director_in",
      "role": "gedelegeerd_bestuurder",
      "person": {
        "rrn": null,
        "name": "Sonia Hollies",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-08-29",
      "evidence_quote": "De bestuurders beslissen om mevrouw Sonia Hollies te delegeren met het dagelijks bestuur van de Vennootschap en haar te benoemen als gedelegeerd bestuurder van de Vennootschap met ingang vanaf heden."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
18-06-2024 Paul Eelen reappointed as statutory auditor Director changes
  • Paul Eelen, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Eelen",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BV EY Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De enige aandeelhouder herbenoemt tot commissaris voor een periode van drie jaar de BV EY Bedrijfsrevisoren (B00160), met maatschappelijke zetel te 1831 Machelen, Kouterveldstraat 7B, bus 1, die overeenkomstig artikel 3:58 van het Wetboek van Vennootschappen en Verenigingen als vertegenwoordiger aan"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
15-03-2024 Registered office moved from Nazareth to Gent Registered-office change
  • Venecoweg 26, 9810 Nazareth → Gaston Crommenlaan 6, 9050 Gent
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "Gent",
        "region": "Vlaams Gewest",
        "street": "Gaston Crommenlaan",
        "country": "BE",
        "postcode": "9050",
        "box_number": "606",
        "street_number": "6"
      },
      "old_address": {
        "city": "Nazareth",
        "region": "Vlaams Gewest",
        "street": "Venecoweg",
        "country": "BE",
        "postcode": "9810",
        "box_number": null,
        "street_number": "26"
      },
      "effective_date": "2024-04-15",
      "evidence_quote": "Conform artikel 2 van de statuten besluit de raad van bestuur om de zetel van de Vennootschap verplaatsen naar 9050 Gent (Ledeberg), Gaston Crommenlaan 6, bus 606, Zuiderpoort Office Park, Atrium B, met ingang van 15 april 2024."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
07-03-2024 Mira De Maeyer appointed as director Director changes
  • Mira De Maeyer, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Mira De Maeyer",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2024-01-01",
      "evidence_quote": "De algemene vergadering benoemt tot bestuurder, met ingang 1 januari 2024, voor een periode van 6 jaar, Mira De Maeyer, wonende te 1700 Dilbeek, Rondebosstraat 80."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2023
01-03-2023 Magali Verbraeken appointed as director Director changes
  • Magali Verbraeken, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Magali Verbraeken",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2023-01-23",
      "evidence_quote": "De algemene vergadering benoemt Magali Verbraeken, wonende te Scheldeveldestraat 27, 9840 De Pinte, als bestuurder van de Vennootschap, met ingang van heden, voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
05-01-2023 Change in the board of directors Director changes
Summary: v3.2
Technical details 
{
  "events": [],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2021
09-09-2021 Gianluca Parola appointed as director Director changes
  • Gianluca Parola, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Gianluca Parola",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-07-29",
      "evidence_quote": "De algemene vergadering benoemt, met ingang van heden, Gianluca Parola, wonende te Itali\u00EB, 20124 Milaan, Via Arzaga 30, tot bestuurder voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
02-09-2021 Articles of association amended Statutes amendment
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "statute_change": {
    "name_change": false,
    "seat_change": false,
    "object_change": false,
    "effective_date": "2021-08-25",
    "legal_form_change": false
  },
  "bedrijfsrevisor": null,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  },
  "signature_regime": "joint_two",
  "special_mandates": [
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Nele DESUTTER",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Jennifer DE MEYER",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Anja VAN WINSBERGHE",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    },
    {
      "quote": "bijzondere volmacht, met recht van indeplaatsstelling, verlenen aan mevrouw Nele DESUTTER, mevrouw Jennifer DE MEYER, mevrouw Anja VAN WINSBERGHE en mevrouw Anouk VAN HECKE, allen woonplaats kiezende op de zetel van de vennootschap, om alle administratieve formaliteiten te vervullen in verband met deze geruisloze parti\u00EBle splitsing en wijziging van de statuten, en in het bijzonder de formaliteiten bij \u00E9\u00E9n of meer erkende ondernemingsloketten en/of bij de btw-administratie.",
      "holder_kbo": null,
      "holder_name": "Anouk VAN HECKE",
      "scope_categories": [
        "administrative_formalities",
        "KBO",
        "tax"
      ],
      "with_substitution": true
    }
  ],
  "governance_change": {
    "admin_delegated_added": []
  }
}
17-06-2021 Publication in the Belgian Official Gazette, Miscellaneous Miscellaneous·Anja Van Winsberghe
Summary: proposalNotary: Anja Van Winsberghe · Gent
Technical details 
{
  "stage": "proposal",
  "notary": {
    "name": "Anja Van Winsberghe",
    "firm_city": null,
    "firm_name": null,
    "office_city": "Gent",
    "is_associated": false
  },
  "act_meta": {
    "language": "nl",
    "pub_date": "2021-06-17",
    "filing_date": "2021-06-09",
    "act_kind_objet": "Voorstel tot geruisloze parti\u00EBle splitsing"
  },
  "decision": {
    "body": "raad_van_bestuur",
    "act_date": "2021-05-26",
    "unanimous": null
  },
  "conversion": null,
  "detected_kind": "demerger_partial",
  "report_waiver": null,
  "restructuring": {
    "parties": [
      {
        "kbo": "0884.084.724",
        "name": "Omega Pharma Innovation \u0026 Development NV",
        "role": "demerged",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      },
      {
        "kbo": "0431.676.229",
        "name": "Perrigo Holding NV",
        "role": "recipient",
        "address": "Venecoweg 26, 9810 Nazareth",
        "is_foreign": false,
        "legal_form": "NV",
        "is_new_company": false,
        "jurisdiction_country": null
      }
    ],
    "exchange_ratio": null,
    "legal_articles": [
      "12:8, 2\u00B0",
      "12:59"
    ],
    "is_cross_border": false,
    "is_silent_merger": false,
    "balance_basis_date": "2020-12-31",
    "exchange_ratio_text": null,
    "new_shares_issued_n": 0,
    "real_estate_included": false,
    "patrimony_description": "De overdracht betreft een gedeelte van het vermogen van Omega Pharma Innovation \u0026 Development NV, met name aandelen in tien dochterondernemingen (waaronder Perrigo Pharma Holding Netherlands BV, Perrigo Italia Srl, Perrigo Espa\u00F1a SA, etc.) en de bijbehorende passiva. De activa en passiva worden overgedragen op basis van de jaarrekening afgesloten per 31 december 2020.",
    "equity_transferred_eur": 370815430.62,
    "accounting_effective_date": "2021-01-01"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "Omega Pharma Innovation \u0026 Development NV",
    "legal_form": "NV"
  },
  "publication_proxy": {
    "kind": "person",
    "org_kbo": null,
    "org_name": null,
    "person_name": "Anja Van Winsberghe",
    "org_rep_person_name": null
  },
  "summary_narrative": "De raad van bestuur van Omega Pharma Innovation \u0026 Development NV en Perrigo Holding NV stellen voor om een geruisloze parti\u00EBle splitsing uit te voeren, waarbij een gedeelte van het vermogen van Omega Pharma Innovation \u0026 Development NV \u2014 met name aandelen in diverse dochterondernemingen \u2014 wordt overgedragen naar Perrigo Holding NV. De splitsing is geruisloos, omdat de verkrijgende vennootschap reeds alle aandelen van de gesplitste vennootschap bezit. De overdracht is gebaseerd op de jaarrekening afgesloten per 31 december 2020 en wordt boekhoudkundig geacht vanaf 1 januari 2021 te zijn verricht",
  "co_filed_documents": [],
  "detected_real_type": "demerger_proposal",
  "referenced_correction": null,
  "should_reroute_to_category": null
}
02-06-2021 1 director appointed, 1 reappointed Director changes
  • Anja van Winsberghe, Bestuurder
  • Paul Eelen, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Anja van Winsberghe",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2021-05-17",
      "evidence_quote": "De algemene vergadering benoemt, met ingang van heden, Anja van Winsberghe wonende te Molenhoekstraat 22, 8980 Zonnebeke, tot bestuurder voor een periode van 6 jaar."
    },
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Eelen",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BV EY Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2021-05-17",
      "evidence_quote": "De algemene vergadering herbenoemt tot commissaris voor een periode van drie jaar de BV EY Bedrijfsrevisoren (B00160), met maatschappelijke zetel te 1831 Diegem, De Kleetlaan 2, die overeenkomstig artikel 3:58 van het Wetboek van Vennootschappen en Verenigingen als vertegenwoordiger aanduidt de venn"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2020
24-07-2020 Lieven Costers reappointed as director Director changes
  • Lieven Costers, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_renew",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lieven Costers",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Pachtersbos BV",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2020-01-01",
      "evidence_quote": "De algemene vergadering herbenoemt, met ingang van 1 januari 2020, Pachtersbos BV, met zetel te 9310 Aalst-Baardegem, Cassestraat 5, vertegenwoordigd door Lieven Costers, vaste vertegenwoordiger, wonende te 9310 Aalst-Baardegem, Cassestraat 5, tot bestuurder, voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2019
28-05-2019 Publication in the Belgian Official Gazette, Minor change Minor change
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "detected_kind": "agm_rescheduling",
  "effective_date": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, EN ABREGE : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "SA"
  },
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "single_shareholder_declaration": null
}
2018
09-07-2018 Paul Eelen reappointed as statutory auditor Director changes
  • Paul Eelen, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_renew",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Paul Eelen",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "BCVBA Ernst \u0026 Young Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering herbenoemt tot commissaris voor een periode van drie jaar de BCVBA Ernst \u0026 Young Bedrijfsrevisoren (B00160), met maatschappelijke zetel te 1831 Diegem, De Kleetlaan 2, die overeenkomstig artikel 132 van het Wetboek van vennootschappen als vertegenwoordiger aanduidt de vennoot"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, EN ABREGE : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "SA"
  }
}
2017
06-10-2017 3 directors appointed Director changes
  • Patrick O'Sullivan, Bestuurder
  • Geert Cools, Bestuurder
  • Lieven Costers, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Patrick O\u0027Sullivan",
        "address": null,
        "birth_date": null
      },
      "effective_date": "2017-09-15",
      "evidence_quote": "De algemene vergadering benoemt, met ingang van 15 september 2017, Patrick O\u0027Sullivan, wonende te 9000 Gent, Galgenberg 23H, tot bestuurder voor een periode van 6 jaar."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Geert Cools",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Brandracer BVBA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Brandracer BVBA Bestuurder vertegenwoordigd door Geert Cools vaste vertegenwoordiger"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Lieven Costers",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Pachtersbos BVBA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "Pachtersbos BVB\u0410 Bestuurder Vertegenwoordigd door Lieven Costers vaste vertegenwoordiger"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2016
20-04-2016 Geert Cools appointed as director Director changes
  • Geert Cools, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Geert Cools",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "Brandracer BVBA",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "effective_date": "2016-02-22",
      "evidence_quote": "De algemene vergadering benoemt, met ingang van 22 februari 2016, Brandracer BVBA, met zetel te 1800 Vilvoorde, Lindenstraat 162, vertegenwoordigd door Geert Cools, vaste vertegenwoordiger, wonende te 1800 Vilvoorde, Lindenstraat 162, tot bestuurder voor een periode van 6 jaar."
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2015
27-07-2015 3 directors appointed Director changes
  • BCVBA Enst & Young Bedrijfsrevisoren, Commissaris
  • Calisco BVBA, Bestuurder
  • Griet Vandenheede BVBA, Bestuurder
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "BCVBA Enst \u0026 Young Bedrijfsrevisoren",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "De algemene vergadering benoemt tot commissans voor een periode van drie jaar de BCVBA Enst \u0026 Young Bedrijfsrevisoren (B00160) ... welke belast wordt met de uitoefening van het mandaat."
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Calisco BVBA",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Calisco BVBA Bestuurder"
    },
    {
      "kind": "director_in",
      "role": "bestuurder",
      "person": {
        "rrn": null,
        "name": "Griet Vandenheede BVBA",
        "address": null,
        "birth_date": null
      },
      "evidence_quote": "Griet Vandenheede BVBA Bestuurder"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "OMEGA PHARMA INNOVATION \u0026 DEVELOPMENT, AFGEKORT : OPID INNOVATION \u0026 DEVELOPMENT",
    "legal_form": "NV"
  }
}
2011
23-03-2011 Peter Opsomer appointed as statutory auditor Director changes
  • Peter Opsomer, Commissaris
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "commissaris_in",
      "role": "commissaris",
      "person": {
        "rrn": null,
        "name": "Peter Opsomer",
        "address": null,
        "birth_date": null
      },
      "via_org": {
        "kbo": null,
        "name": "PricewaterhouseCoopers Bedrijfsrevisoren",
        "address": null,
        "country": null,
        "legal_form": null
      },
      "evidence_quote": "De algemene vergadering benoemt tot commissaris voor een periode van drie jaar de Burgerlijke vennootschap die de vorm heeft aangenomen van een co\u00F6peratieve vennootschap met beperkte aansprakelijkheid PricewaterhouseCoopers Bedrijfsrevisoren (B00009), met maatschappelijke zetel te 1932 Sint-Stevens-"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "LABORATOIRES DUHOT",
    "legal_form": "SA"
  }
}
03-01-2011 Publication in the Belgian Official Gazette, Minor change Minor change
Summary: v3.2
Technical details 
{
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "detected_kind": "fiscal_year_change",
  "effective_date": null,
  "mandate_renewal": null,
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "LABORATOIRES DUHOT",
    "legal_form": "SA"
  },
  "liquidation_closure": null,
  "officer_designation": null,
  "special_procuration": null,
  "single_shareholder_declaration": null
}
2009
10-07-2009 Registered office moved from LIMAL to FROYENNES Registered-office change
  • Avenue de Nivelles 7, 1300 LIMAL → Rue de l'Innovation 1, 7503 FROYENNES
Summary: v3.2
Technical details 
{
  "events": [
    {
      "kind": "zetel_transfer",
      "seat_type": "statutaire",
      "new_address": {
        "city": "FROYENNES",
        "region": null,
        "street": "Rue de l\u0027Innovation",
        "country": "BE",
        "postcode": "7503",
        "box_number": "A",
        "street_number": "1"
      },
      "old_address": {
        "city": "LIMAL",
        "region": null,
        "street": "Avenue de Nivelles",
        "country": "BE",
        "postcode": "1300",
        "box_number": null,
        "street_number": "7"
      },
      "effective_date": "2009-05-04",
      "evidence_quote": "Transfert du si\u00E8ge social \u00E0 l\u0027adresse suivante: Rue de l\u0027Innovation 1A \u00E0 7503 FROYENNES"
    }
  ],
  "schema": "v3.2",
  "act_meta": {
    "model_id": 36,
    "extractor": "constrained-core-35b"
  },
  "subject_company": {
    "kbo": "0884.084.724",
    "name_full": "LABORATOIRES DUHOT",
    "legal_form": "SA"
  }
}
Credit advice verdict per customer and amount

May this customer buy amount X on invoice? Enter the amount and the payment term. This page computes a GREEN, AMBER or RED verdict from them, with a suggested ceiling and concrete conditions.

Based on official sources (NBB, CBE, State Gazette). Indicative, not credit advice.
Company registry (CBE) Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72109Speur- en ontwikkelingswerk op biotechnologisch gebied72110Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied72190Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied73100
Primary activity highlighted.
Names & trade names
Legal nameFR OMEGA PHARMA INNOVATION & DEVELOPMENT
AbbreviationFR OPID
AbbreviationNL INNOVATION & DEVELOPMENT
Registered office
Gaston Crommenlaan 6 bus 606
9050 Gent, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies Same sector and region · no size comparison possible · 147 of 1,175 with filed accounts
CLOUDS OF CARE BE 0664.618.462 · Gent
FENIKX BE 0806.902.220 · Gent
JW Hoste BE 0784.873.421 · Gent
4U2 PATENT SERVICE BE 0534.773.569 · Oudenaarde
ABLYNX BE 0475.295.446 · Gent
Source: Belgian State Gazette, CBE, NBB · generated via checked.be · indicative